Business Segments · Total assets of reportable segments
MedSurg — Total assets of reportable segments
Boston Scientific MedSurg — Total assets of reportable segments increased by 9.8% to $3.73B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 19.2%, from $3.13B to $3.73B.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2019
Last reportedQ1 2026May 1, 2026
Rolls up toOther Non-Current Assets
How to read this metric
Growth in assets relative to sales may indicate capital expansion, while a decline relative to sales might suggest improved asset turnover efficiency.
Detailed definition
The total value of assets directly attributable to the MedSurg segment, including inventory, property, plant, equipment,...
Peer comparison
Commonly reported as 'Segment Assets' in the notes to financial statements for diversified corporations.
Metric ID:
bsx_segment_medsurg_total_assets_of_reportable_segmentsHistorical Data
9 periods
| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $2.18B | $2.5B | $2.89B | $3.09B | $3.13B | $3.33B | $3.39B | $3.39B | $3.73B |
| QoQ Change | — | +14.8% | +15.5% | +7.1% | +1.1% | +6.5% | +1.8% | +0.0% | +9.8% |
| YoY Change | — | +14.8% | +15.5% | +7.1% | — | — | — | +9.7% | +19.2% |
Range$2.18B – $3.73B
CAGR+30.8%
Avg YoY Growth+13.2%
Median YoY Growth+14.8%
Current Streak8+ quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Boston Scientific's medsurg — total assets of reportable segments?
- Boston Scientific (BSX) reported medsurg — total assets of reportable segments of $3.73B in Q1 2026.
- How has Boston Scientific's medsurg — total assets of reportable segments changed year-over-year?
- Boston Scientific's medsurg — total assets of reportable segments increased by 19.2% year-over-year, from $3.13B to $3.73B.
- What does medsurg — total assets of reportable segments mean?
- The total value of assets dedicated to the MedSurg business unit.